Japan Generics Mandate Leads To Reduction In Maker Portfolios
This article was originally published in PharmAsia News
Executive Summary
Japan's three-year-old policy regarding generic drugs is beginning to lead pharmaceutical companies to focus their marketing efforts on top sellers